FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2950360144> ?p ?o ?g. }

• W2950360144 abstract "Cobra venom factor (CVF) is the complement-activating protein in cobra venom. CVF is a structural and functional analog of complement component C3. CVF, like C3b, forms a convertase with factor B. This bimolecular complex CVF,Bb is an enzyme that cleaves C3 and C5. However, CVF,Bb exhibits significantly different functional properties from C3b,Bb. The CVF,Bb convertase is physico-chemically very stable, and completely resistant to an activation by Factors H and I. These two properties, in contrast to C3b,Bb, allow continuous activation of C3 and C5, and complement depletion in serum. In order to understand the structural basis for the functional differences between CVF and C3, we have created several hybrid proteins of CVF and human C3. Here we report that replacing the C-terminal 168 amino acid residues of human C3 with the corresponding residues from CVF results in a hybrid protein (HC3-1496) which is essentially a human C3 derivative exhibiting the functional properties of CVF. This result demonstrates that the important structures for the CVF-specific functions reside within the C-terminal 168 amino acid residues of CVF. We further demonstrate that reverting the 46 C-terminal CVF residues of HC3-1496 to human C3 sequence results in a hybrid protein (HC3-1496/1617) that exhibits a physico-chemically unstable convertase with only residual complement depleting activity. This result demonstrates that most, but not all, structural requirements for CVF activity reside within the 46 C-terminal amino acid residues. We also investigated the potential role of position 1633, which is an acidic residue in human C3 (glutamic acid) but a basic amino acid residue (histidine) in CVF. However, the charge at position 1633 appears to be of no functional relevance. Exchanging the neutral amino acids present in CVF at positions 1499 and 1501 with the two charged amino acids at these positions in human C3 (aspartic acid and lysine) resulted in a hybrid protein that exhibited significantly slower convertase formation although both binding to Factor B and C3 cleavage was not affected, demonstrating that the charged amino acid residues at these two positions interfere with the formation of the convertase. In conclusion, our work demonstrates that hybrid proteins of human C3 and CVF present valuable tools to identify functionally important amino acid residues in CVF." @default.
• W2950360144 created "2019-06-27" @default.
• W2950360144 creator A5005122560 @default.
• W2950360144 creator A5031646242 @default.
• W2950360144 creator A5041083283 @default.
• W2950360144 creator A5043866477 @default.
• W2950360144 date "2019-09-01" @default.
• W2950360144 modified "2023-10-03" @default.
• W2950360144 title "Identification of functionally important amino acid sequences in cobra venom factor using human C3/Cobra venom factor hybrid proteins" @default.
• W2950360144 cites W1243584887 @default.
• W2950360144 cites W1247518833 @default.
• W2950360144 cites W1480087746 @default.
• W2950360144 cites W1480549675 @default.
• W2950360144 cites W1483293311 @default.
• W2950360144 cites W1491564174 @default.
• W2950360144 cites W1497166035 @default.
• W2950360144 cites W1526236792 @default.
• W2950360144 cites W1539438750 @default.
• W2950360144 cites W1543907558 @default.
• W2950360144 cites W1579655177 @default.
• W2950360144 cites W1587653132 @default.
• W2950360144 cites W1668570738 @default.
• W2950360144 cites W1873912294 @default.
• W2950360144 cites W1952707006 @default.
• W2950360144 cites W1967901145 @default.
• W2950360144 cites W1968039404 @default.
• W2950360144 cites W1968935539 @default.
• W2950360144 cites W1975514562 @default.
• W2950360144 cites W1981194189 @default.
• W2950360144 cites W1995640513 @default.
• W2950360144 cites W2018907475 @default.
• W2950360144 cites W2020429292 @default.
• W2950360144 cites W2039587750 @default.
• W2950360144 cites W2043726144 @default.
• W2950360144 cites W2045366723 @default.
• W2950360144 cites W2051156677 @default.
• W2950360144 cites W2054898584 @default.
• W2950360144 cites W2060913542 @default.
• W2950360144 cites W2067611247 @default.
• W2950360144 cites W2075021230 @default.
• W2950360144 cites W2077110004 @default.
• W2950360144 cites W2084969272 @default.
• W2950360144 cites W2087184100 @default.
• W2950360144 cites W2090977381 @default.
• W2950360144 cites W2091933198 @default.
• W2950360144 cites W2107312689 @default.
• W2950360144 cites W2117807431 @default.
• W2950360144 cites W2134493315 @default.
• W2950360144 cites W2141596893 @default.
• W2950360144 cites W2144278357 @default.
• W2950360144 cites W2155580358 @default.
• W2950360144 cites W2157932363 @default.
• W2950360144 cites W2166320123 @default.
• W2950360144 cites W2169194436 @default.
• W2950360144 cites W2312921356 @default.
• W2950360144 cites W2769006113 @default.
• W2950360144 cites W2797769718 @default.
• W2950360144 cites W2907468602 @default.
• W2950360144 cites W343272032 @default.
• W2950360144 cites W832974056 @default.
• W2950360144 cites W1891397857 @default.
• W2950360144 cites W2019344613 @default.
• W2950360144 doi "https://doi.org/10.1016/j.toxicon.2019.06.017" @default.
• W2950360144 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31207349" @default.
• W2950360144 hasPublicationYear "2019" @default.
• W2950360144 type Work @default.
• W2950360144 sameAs 2950360144 @default.
• W2950360144 citedByCount "1" @default.
• W2950360144 countsByYear W29503601442020 @default.
• W2950360144 crossrefType "journal-article" @default.
• W2950360144 hasAuthorship W2950360144A5005122560 @default.
• W2950360144 hasAuthorship W2950360144A5031646242 @default.
• W2950360144 hasAuthorship W2950360144A5041083283 @default.
• W2950360144 hasAuthorship W2950360144A5043866477 @default.
• W2950360144 hasConcept C104317684 @default.
• W2950360144 hasConcept C111684460 @default.
• W2950360144 hasConcept C112313634 @default.
• W2950360144 hasConcept C127716648 @default.
• W2950360144 hasConcept C159654299 @default.
• W2950360144 hasConcept C167625842 @default.
• W2950360144 hasConcept C182629451 @default.
• W2950360144 hasConcept C185592680 @default.
• W2950360144 hasConcept C188082640 @default.
• W2950360144 hasConcept C189446657 @default.
• W2950360144 hasConcept C199360897 @default.
• W2950360144 hasConcept C203014093 @default.
• W2950360144 hasConcept C2779448229 @default.
• W2950360144 hasConcept C2779547071 @default.
• W2950360144 hasConcept C41008148 @default.
• W2950360144 hasConcept C515207424 @default.
• W2950360144 hasConcept C55493867 @default.
• W2950360144 hasConcept C86803240 @default.
• W2950360144 hasConcept C9478725 @default.
• W2950360144 hasConceptScore W2950360144C104317684 @default.
• W2950360144 hasConceptScore W2950360144C111684460 @default.
• W2950360144 hasConceptScore W2950360144C112313634 @default.
• W2950360144 hasConceptScore W2950360144C127716648 @default.
• W2950360144 hasConceptScore W2950360144C159654299 @default.
• W2950360144 hasConceptScore W2950360144C167625842 @default.
• W2950360144 hasConceptScore W2950360144C182629451 @default.

• next